MedTrace Logo

Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

NCT03904667 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-04-05

No results posted yet for this study

Summary

The aim of this study was to evaluate the surgical decisions of Watson artificial intelligence in patients with hepatocellular carcinoma.

Conditions

  • Liver Resection

Interventions

OTHER

Watson on oncology surgery decision evaluation

Watson on oncology surgery decision evaluation. The system acquires and evaluates a large amount of structured and unstructured data from previous medical records through machine learning and natural language processing, and USES algorithms to select treatment options as the best choice for a particular patient.

Sponsors & Collaborators

  • Zhujiang Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03904667 on ClinicalTrials.gov